Skip to main content

Advertisement

Log in

Polygenic risk score and biochemical/environmental variables predict a low-risk profile of age-related macular degeneration in Sardinia

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To ascertain the prevalence and clinical and genetic features of age-related macular degeneration (AMD) in subjects living in the Lanusei valley, Central Sardinia, Italy, involved in a study on ageing (SardiNIA project).

Methods

A total of 814 volunteers aged ≥ 50 years, randomly selected from the SardiNIA project dataset, were included. A color fundus (CF) photograph of the 30° central retina of each eye was obtained and graded according to the Age-Related Eye Disease Study system. Life-style choices were investigated using standardized questionnaires. The concentrations of several inflammatory biomarkers (i.e., complement component, fibrinogen, and C-reactive protein) were measured. Polygenic risk score (PRS) was calculated and compared with results obtained from a European cohort.

Results

A total of 756 subjects had gradable CF photographs for AMD detection. In 91.3%, no signs of AMD were observed. The prevalence rates of early and late AMDs were 6.9% and 0.6%, respectively. A total of 85% of subjects were physically active; only 13.5% were current smokers. Low concentrations of complement component, fibrinogen, and C-reactive protein were found. We calculated the polygenic risk scores (PRS) using 40 AMD markers distributed on several candidate genes in Europeans and Sardinians. The mean PRS value was significantly lower in Sardinians than in the Europeans (0.21 vs. 0.248, respectively, p = 1.18 × 10−77).

Conclusions

In our cohort, most subjects showed no sign of any AMD type and late AMD was a condition rarely observed. Results of genetic, biochemical, and life-style investigation support the hypothesis that Sardinia population may present of a peculiar background with a protective effect against AMD development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Resnikoff S, Pascolini D, Etya’ale D et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851

    PubMed  PubMed Central  Google Scholar 

  2. Ehrlich R, Harris A, Kheradiya NS, Winston DM et al (2008) Age-related macular degeneration and the aging eye. Clin Interv Aging 3(3):473–482. https://doi.org/10.2147/cia.s2777

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lim LS, Mitchell P, Jm S et al (2012) Age-related macular degeneration. Lancet 379:1728–1738. https://doi.org/10.1016/S0140-6736(12)60282-7

    Article  PubMed  Google Scholar 

  4. Freund KB, Zweifel SA, Engelbert M (2010) Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30:1333–1349. https://doi.org/10.1097/IAE.0b013e3181e7976b

    Article  PubMed  Google Scholar 

  5. Bowes Rickman C, Farsiu S, Toth CA et al (2013) Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci 54:ORSF68–ORSF80. https://doi.org/10.1167/iovs.13-12757

    Article  PubMed  PubMed Central  Google Scholar 

  6. Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122:598–614. https://doi.org/10.1001/archopht.122.4.598

    Article  PubMed  Google Scholar 

  7. Age-Related Eye Disease Study Research Group (2000) Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107:2224–2232. https://doi.org/10.1016/s0161-6420(00)00409-7

    Article  Google Scholar 

  8. Piermarocchi S, Segato T, Scopa P et al (2011) The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol 18:129–136. https://doi.org/10.3109/09286586.2011.574334

    Article  PubMed  Google Scholar 

  9. Vingerling JR, Dielemans I, Hofman A et al (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102(2):205–210. https://doi.org/10.1016/s0161-6420(95)31034-2

    Article  CAS  PubMed  Google Scholar 

  10. Seddon JM, Cote J, Page WF et al (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123(3):321–327. https://doi.org/10.1001/archopht.123.3.321

    Article  PubMed  Google Scholar 

  11. Winkler TW, Grassmann F, Brandl C et al (2020) Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease. BMC Med Genomics 13:120. https://doi.org/10.1186/s12920-020-00760-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Pes GM, Tolu F, Dore MP et al (2015) Male longevity in Sardinia, a review of historical sources supporting a causal link with dietary factors. Eur J Clin Nutr 69:411–418. https://doi.org/10.1038/ejcn.2014.230

    Article  CAS  PubMed  Google Scholar 

  13. Polidori MC, Mariani E, Baggio G et al (2007) Different antioxidant profiles in Italian centenarians: the Sardinian peculiarity. Eur J Clin Nutr 61:922–924. https://doi.org/10.1038/sj.ejcn.1602596

    Article  CAS  PubMed  Google Scholar 

  14. Pilia G, Chen WM, Scuteri A et al (2006) Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet 2:e132. https://doi.org/10.1371/journal.pgen.0020132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417–1436. https://doi.org/10.1001/archopht.119.10.1417

  16. Davis MD, Gangnon RE, Lee LY et al (2005) Age-Related Eye Disease Study Group The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 17. Arch Ophthalmol 123:1484–1498. https://doi.org/10.1001/archopht.123.11.1484

    Article  PubMed  Google Scholar 

  17. Pennington KL, DeAngelis MM (2016) Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond) 3:34. https://doi.org/10.1186/s40662-016-0063-5

    Article  PubMed  Google Scholar 

  18. Klaver CC, Klifen M, van Duijn CM et al (1998) Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63(1):200–206. https://doi.org/10.1086/301901

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Smith W, Mitchell P, Leeder SR et al (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116(5):583–587. https://doi.org/10.1001/archopht.116.5.583

    Article  CAS  PubMed  Google Scholar 

  20. Allain CC, Poon LS, Chan CS et al (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475

    Article  CAS  PubMed  Google Scholar 

  21. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52–58

    Article  CAS  PubMed  Google Scholar 

  22. Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 17:237–246. https://doi.org/10.1159/000205234

    Article  CAS  PubMed  Google Scholar 

  23. Sidore C, Busonero F, Maschio A et al (2015) Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat Genet 47:1272–1281. https://doi.org/10.1038/ng.3368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Orrù V, Steri M, Sidore C et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52:1036–1045. https://doi.org/10.1038/s41588-020-0684-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Fritsche LG, Igl W, Bailey JN et al (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48:134–143. https://doi.org/10.1038/ng.3448

    Article  CAS  PubMed  Google Scholar 

  26. UK10K Consortium, Walter K, Min JL et al (2015) The UK10K project identifies rare variants in health and disease. Nature 526:82–90. https://doi.org/10.1038/nature14962

    Article  CAS  Google Scholar 

  27. Tomany SC, Klein R, Klein BE, Beaver Dam Eye Study (2003) The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 110:1526–1533. https://doi.org/10.1016/s0161-6420(03)00539-6

    Article  PubMed  Google Scholar 

  28. Mallocci M, Loi-Zedda A, Palmas M et al (2006) Low frequency of the CFH polymorphism T1277C contributes to a low prevalence of AMD in a Sardinian genetic isolate. DOG 2006 online https://iovs.arvojournals.org/article.aspx?articleid=2395113. ARVO Annual Meeting Abstract

  29. Li M, Atmaca-Sonmez P, Othman M et al (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38(9):1049–1054. https://doi.org/10.1038/ng1871

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Laine M, Jarva H, Seitsonen S et al (2007) Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol 178:3831–3836. https://doi.org/10.4049/jimmunol.178.6.3831

    Article  CAS  PubMed  Google Scholar 

  31. Carneiro Â, Andrade JP (2017) Nutritional and lifestyle interventions for age-related macular degeneration: a review. Oxid Med Cell Longev 2017:6469138. https://doi.org/10.1155/2017/6469138

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all the volunteers who generously participated in this study and made this research possible.

Funding

This study was funded by contracts N01‐AG‐1‐2109 and HHSN271201600005C from the Intramural Research Program of the National Institute on Aging, National Institutes of Health (NIH).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Rita Serra or Andrea Angius.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the (place name of institution and/or national research committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rita Serra and Vincenzo Rallo are joint first authors.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Serra, R., Rallo, V., Pinna, A. et al. Polygenic risk score and biochemical/environmental variables predict a low-risk profile of age-related macular degeneration in Sardinia. Graefes Arch Clin Exp Ophthalmol 261, 691–698 (2023). https://doi.org/10.1007/s00417-022-05858-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-022-05858-5

Keywords

Navigation